Franzmann, Alexandra

Referentin für Statistik [bis 2012], Deutsches Arzneiprüfungsinstitut e. V. (DAPI), Eschborn [bis 2012]

2002 - 2012

Referentin für Statistik am Deutschen Arzneiprüfungsinstitut (DAPI), Eschborn

Publications:

Pharmacy refill adherence with antidepressants.

Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany

Medication persistence with ginkgo biloba drugs of different dosage strengths - Persistenz bei Ginkgo biloba-Arzneimitteln unterschiedlicher Wirkstärke.

Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study.

Marktanteilsanalyse zum AOK-Rabattvertrag

Marktanteilsanalyse zum TK-Rabattvertrag

Zielpreise für Leitsubstanzen: Verantwortungsteilung zwischen Arzt und Apotheker

Non-Compliance – das unterschätzte Problem: Neue Möglichkeiten der Erfassung über Datenbankanalysen

Utilizing claims data to assess persistence with antidepressants.

Incidence of thyroid hormone therapy in patients treated with sorafenib or sunitinib

Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.

Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.

Beeinflusst die Umstellung von Risedronat oder Alendronat Originalprodukten auf Generika die Compliance (Persistenz)?

Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany

Switching from branded alendronate or risedronate to generic alendronate: effect on persistence with bisphosphonate therapy in Germany

Statine – Verordnungsanalyse und Praxistipps

Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.